Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FD8WA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,739
Award facts
- Contract value 100% obligated
- $7,738.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,738.94 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pre-filled pens. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply agreement running through December 2026 that supports military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency and affiliated healthcare systems. The company's federal contracts demonstrate consistent capability in supplying a diverse range of medications across multiple therapeutic domains, including specialty pharmaceuticals, brand-name and generic drugs, and medical devices. This particular delivery order for Zepbound, a diabetes and weight management medication, reflects the company's role in supporting medical supply chain requirements for military and veteran healthcare systems through the DLA's Pharmaceutical Prime Vendor Global Program.
Quick answers
Who was awarded contract SPE2DB25FD8WA?
SPE2DB25FD8WA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FD8WA worth?
The government has obligated $7,739 on SPE2DB25FD8WA.
Is contract SPE2DB25FD8WA an order under another contract?
Yes. SPE2DB25FD8WA is a delivery order under SPE2DB20D1051, an indefinite delivery contract.
Was contract SPE2DB25FD8WA competed?
The extent of competition for SPE2DB25FD8WA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award